Acumen Pharmaceuticals, Inc. (ABOS) Net income 2020–2025
Acumen Pharmaceuticals, Inc. (ABOS) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$121.3MFY2025 · since FY2020: -$7.3M → -$121.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$121.3M | -18.6% |
| FY2024 | -$102.3M | -95.4% |
| FY2023 | -$52.4M | -22.2% |
| FY2022 | -$42.9M | +57.4% |
| FY2021 | -$100.6M | -1273.5% |
| FY2020 | -$7.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice